![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Abbott Medical St. Paul Us, based in China, is a pharmaceutical company.
One of their significant offerings is Glutaraldehyde fixed bovine pericardium, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2015-381 - Rev 01
This TSE Type CEP, issued on October 25, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.